Reagent Core

$151,006U19FY2016AINIH

Icahn School Of Medicine At Mount Sinai, New York NY

Investigators

Linked publications & trials

Paper 38805853 Paper 37624867 Paper 37066221 Paper 36533948 Paper 35461522 Paper 35183062 Paper 34942633 Paper 34781736 Paper 34358128 Paper 34312615 Paper 34126773 Paper 34078743 Paper 34067435 Paper 34022127 Paper 33529172 Paper 33468695 Paper 33440898 Paper 33303605 Paper 33298562 Paper 33288923 Paper 33096040 Paper 32995763 Paper 32935099 Paper 32661157 Paper 31951517 Paper 31630990 Paper 31497029 Paper 31375573 Paper 31105689 Paper 31004012 Paper 30944178 Paper 30795982 Paper 30728266 Paper 30626682 Paper 30539468 Paper 30518651 Paper 30457979 Paper 30381487 Paper 30188868 Paper 30151588 Paper 30135514 Paper 30045991 Paper 30001520 Paper 29992986 Paper 29944764 Paper 29899095 Paper 29899093 Paper 29890370 Paper 29739835 Paper 29680576 Paper 29641537 Paper 29625056 Paper 29617394 Paper 29615508 Paper 29263881 Paper 29250436 Paper 29250435 Paper 29109276 Paper 29018261 Paper 28971969 Paper 28928215 Paper 28910287 Paper 28883436 Paper 28874545 Paper 28872136 Paper 28867526 Paper 28827718 Paper 28813656 Paper 28783670 Paper 28663209 Paper 28630076 Paper 28515302 Paper 28472280 Paper 28446061 Paper 28325769 Paper 28216325 Paper 28192418 Paper 28172415 Paper 28126818 Paper 28094102 Paper 28087938 Paper 27820605 Paper 27730299 Paper 27703076 Paper 27698132 Paper 27694224 Paper 27647907 Paper 27627763 Paper 27600311 Paper 27486196 Paper 27281570 Paper 27268395 Paper 27081859 Paper 27006464 Paper 27001854 Paper 26982359 Paper 26927813 Paper 26787832 Paper 26764009 Paper 26731473

Abstract

This core will provide Projects 1, 2 and 3 as well as the Antibody Core with necessary influenza virus reagents to conduct the proposed research. All three Projects as well as the Antibody Core will greatly benefit from this core's ability to produce a large panel of high quality recombinant influenza virus hemagglutinin and neuraminidase proteins as well as chimeric versions of these molecules. These proteins are functional, correctly folded and glycosylated and will be used in various assays by Project 1. 2 and 3 and as baiting agent by the Antibody Core. Furthermore, the core will produce custom made recombinant viruses that express chimeric hemagglutinin, neuraminidase and chimeric neuraminidase proteins in the influenza A and B virus background. Project 1 will use these viruses for analysis of monoclonal antibodies and for mimicking of preexisting immunity in animal models. Finally, the Reagent Core will supply Projects 1, 2 and 3 as well as the Antibody Core with high titer virus stocks, mouse adapted influenza virus challenge strains and purified virus preparations

View original record on NIH RePORTER →